TSLA

450.52

-3.67%↓

NKE

61.18

-2.66%↓

ORLY

92.6

+2.02%↑

GM

67.33

-1.39%↓

AZO

3,653.49

+3.02%↑

TSLA

450.52

-3.67%↓

NKE

61.18

-2.66%↓

ORLY

92.6

+2.02%↑

GM

67.33

-1.39%↓

AZO

3,653.49

+3.02%↑

TSLA

450.52

-3.67%↓

NKE

61.18

-2.66%↓

ORLY

92.6

+2.02%↑

GM

67.33

-1.39%↓

AZO

3,653.49

+3.02%↑

TSLA

450.52

-3.67%↓

NKE

61.18

-2.66%↓

ORLY

92.6

+2.02%↑

GM

67.33

-1.39%↓

AZO

3,653.49

+3.02%↑

TSLA

450.52

-3.67%↓

NKE

61.18

-2.66%↓

ORLY

92.6

+2.02%↑

GM

67.33

-1.39%↓

AZO

3,653.49

+3.02%↑

Search

Interface Inc

Avatud

SektorTarbekaubad (tsüklilised)

25.99 2.4

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

25.26

Max

26.18

Põhinäitajad

By Trading Economics

Sissetulek

20M

33M

Müük

78M

376M

P/E

Sektori keskmine

17.241

30.703

Dividenditootlus

0.14

Kasumimarginaal

8.671

Töötajad

3,600

EBITDA

28M

60M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+28.51% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.14%

2.96%

Järgmine dividendimakse kuupäev

12. dets 2025

Järgmine aktsia dividendi kuupäev (ex-date)

28. nov 2025

Turustatistika

By TradingEconomics

Turukapital

402M

1.6B

Eelmine avamishind

23.59

Eelmine sulgemishind

25.99

Uudiste sentiment

By Acuity

42%

58%

137 / 372 Pingereas Consumer cyclical

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Interface Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. nov 2025, 21:44 UTC

Tulu

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3. nov 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3. nov 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3. nov 2025, 23:28 UTC

Tulu

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3. nov 2025, 23:24 UTC

Tulu

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. nov 2025, 23:14 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

3. nov 2025, 23:14 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3. nov 2025, 23:12 UTC

Tulu

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. nov 2025, 23:09 UTC

Tulu

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3. nov 2025, 23:09 UTC

Tulu

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3. nov 2025, 23:09 UTC

Tulu

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3. nov 2025, 23:06 UTC

Market Talk
Tulu

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3. nov 2025, 22:36 UTC

Market Talk
Tulu

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3. nov 2025, 22:31 UTC

Tulu

Franco-Nevada 3Q EPS $1.49 >FNV

3. nov 2025, 22:31 UTC

Tulu

Franco-Nevada 3Q Rev $487.7M >FNV

3. nov 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3. nov 2025, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Starbucks Agrees to Sell Stake in China Business -- WSJ

3. nov 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3. nov 2025, 21:54 UTC

Market Talk
Tulu

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3. nov 2025, 21:54 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

3. nov 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. nov 2025, 21:49 UTC

Tulu

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3. nov 2025, 21:40 UTC

Tulu

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3. nov 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3. nov 2025, 21:19 UTC

Tulu

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3. nov 2025, 21:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3. nov 2025, 21:11 UTC

Tulu

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3. nov 2025, 21:07 UTC

Tulu

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3. nov 2025, 21:05 UTC

Tulu

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3. nov 2025, 21:05 UTC

Tulu

Palantir Technologies 3Q Net $475.6M >PLTR

Võrdlus sarnastega

Hinnamuutus

Interface Inc Prognoos

Hinnasiht

By TipRanks

28.51% tõus

12 kuu keskmine prognoos

Keskmine 32 USD  28.51%

Kõrge 32 USD

Madal 32 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Interface Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

18.75 / N/AToetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Very Strong Bullish Evidence

Pikk perspektiiv

Neutral Evidence

Sentiment

By Acuity

137 / 372 Pingereas Tarbekaubad (tsüklilised)

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Interface Inc

Interface, Inc. designs, produces, and sells modular carpet products primarily worldwide. The company operates in two segments, Americas (AMS), and Europe, Africa, Asia and Australia (EAAA). The company offers modular carpets under the Interface and FLOR brand names; luxury vinyl tiles; carpet tiles under the CQuestGB name for use in commercial interiors, include offices, healthcare facilities, airports, educational and other institutions, hospitality spaces, and retail facilities, as well as residential interiors; and modular resilient flooring products. It also provides carpet replacement, installation, and maintenance services; and rubber flooring under the norament and noraplan brand names; as well as produces and sells an adapted version of its carpet tile for the healthcare facilities market. In addition, the company sells a proprietary antimicrobial chemical compound under the Intersept name; sells TacTiles, a carpet tile installation system, as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. The company sells its products directly to end-users, as well as indirectly through independent contractors, installers, or distributors. Interface, Inc. was incorporated in 1973 and is headquartered in Atlanta, Georgia.
help-icon Live chat